COPD Exacerbation Risk May Be Increased by Delayed Start of Triple Therapy
How does a delay in initiating triple therapy affect patients with COPD with a history of several moderate COPD exacerbations during a 1-year period?
CHEST 2022
Conference Coverage
Severe COVID-19 Is Associated With Post-Discharge ILD in Patients Without Cancer
Should patients without cancer who have recovered from severe COVID-19 infection be referred to post-COVID clinics based on their risk for interstitial lung disease?
COPD Severity Appears Not to Affect Coronary Artery Bypass Grafting Outcomes
Researchers assessed the effect of COPD severity on mortality and other outcomes of coronary artery bypass grafting.
Cannabis Use Linked to Fewer Acute Exacerbations of COPD
How does cannabis affect COPD? To determine this, researchers assessed the risk for acute exacerbations of COPD in those who used cannabis vs those who did not.
Omalizumab Improves Outcomes in Allergic Asthma Even With Off-Label Dosing
Can patients with allergic asthma benefit from omalizumab even if they fall outside the criteria put forth in the approved recommended dosing table?
Triple Therapy Linked to Fewer Exacerbations in COPD With Elevated Eosinophils
Post hoc analysis of a real-world COPD trial assessed the effect of triple therapy in reducing exacerbations in patients with higher vs lower eosinophil levels.
Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma
Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.
Extracorporeal Membrane Oxygenation Increases Risk in Certain Comorbidities
Researchers sought to analyze the relationship between patient comorbidities and poor outcomes following ECMO treatment.
Statin Use May Reduce Risk for Lung Cancer in Patients With IPF
A study was conducted to assess if statin use in patients with IPF can prevent development of lung cancer.
Rituximab Reduces Pulmonary Artery Systolic Pressure in ILD-SSc
Researchers studied the changes of pulmonary artery systolic pressure among patients with interstitial lung disease associated with systemic sclerosis receiving rituximab therapy.
Want to read more?
Please login or register first to view this content.